![Utpal Koppikar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 691 129 $ al 31/10/2026
Mr. Utpal Koppikar is an Independent Director at Insmed, Inc., a Chief Financial Officer at Verily Life Sciences LLC and an Independent Director at C4 Therapeutics, Inc. He is on the Board of Directors at Insmed, Inc. and C4 Therapeutics, Inc. Mr. Koppikar was previously employed as a Chief Financial Officer & Senior Vice President by Atara Biotherapeutics, Inc. and a Vice President-Corporate & Operations Finance by Gilead Sciences, Inc. He also served on the board at Flexion Therapeutics, Inc. He received his undergraduate degree from the University of Maryland, a graduate degree from Stanford University and an MBA from UCLA Anderson School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 19/10/2026 | 6.139 ( 0 % ) | 691 129 $ | 31/10/2026 | |
| 24/06/2026 | 0 ( -.--% ) | - $ | 31/10/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| C4 THERAPEUTICS, INC. | Director/Miembro de la Junta | 16/03/2022 |
| INSMED INCORPORATED | Director/Miembro de la Junta | 20/10/2026 |
Verily Life Sciences LLC
 Verily Life Sciences LLC Packaged SoftwareTechnology Services Develops tools to collect and organize health data | Director Financiero/CFO | 01/04/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Director Financiero/CFO | 31/03/2023 |
| FLEXION THERAPEUTICS, INC. | Director/Miembro de la Junta | 19/11/2021 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/06/2018 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Verily Life Sciences LLC
Verily Life Sciences LLC Packaged SoftwareTechnology Services Develops tools to collect and organize health data | Technology Services |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
